BEAM
Beam Therapeutics Inc.
$21.01+0.36 (+1.74%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Feb 6, 2020 – Nov 18, 2026, Dividends reinvested
- Final balance
- $11,205
- CAGR
- +1.69%
- Max drawdown
- −89.12%
Trailing returns (%)
BEAM's average annual return was −25.19% over the last 5 years, through Nov 18, 2026. $10,000 in BEAM on Nov 18, 2021 fell to $2,343 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −10.48%
- 3M
- −20.93%
- 6M
- −21.63%
- YTD
- −24.21%
- 1Y
- −4.15%
Per year
- 3Y
- −8.55%
- 5Y
- −25.19%
- Since 2020
- +1.69%
Annual returns
2020 from Feb 6 · 2026 through Nov 18
BEAM returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −24.21% |
| 2025 | +11.77% |
| 2024 | −8.89% |
| 2023 | −30.40% |
| 2022 | −50.92% |
| 2021 | −2.39% |
| 2020 from Feb 6 | +335.41% |
Metrics
Since 2020| Volatility | 79.57% |
|---|---|
| Sharpe ratio | 0.41 |
| Sortino ratio | 0.64 |
| Calmar ratio | 0.02 |
| Longest drawdown | 5.4 years |
Worst drawdowns
Since 2020| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −89.1% | Jul 2021 | Apr 2025 | Not yet | 5.4 years so far |
| −54.4% | Feb 2020 | Mar 2020 | Jul 2020 | 5 months |
| −46.9% | Feb 2021 | May 2021 | Jun 2021 | 5 months |
| −37.8% | Jul 2020 | Aug 2020 | Oct 2020 | 3 months |
| −20.6% | Jan 2021 | Jan 2021 | Feb 2021 | 3 weeks |